Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-26,10% Owner,HBM Healthcare Investments (Ca ,卖出,709普通股, $11.00
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-21,10% Owner,HBM Healthcare Investments (Ca ,卖出,2622普通股, $11.04
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-20,10% Owner,HBM Healthcare Investments (Ca ,卖出,325普通股, $11.00
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-19,10% Owner,HBM Healthcare Investments (Ca ,卖出,11785普通股, $11.07
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-18,10% Owner,HBM Healthcare Investments (Ca ,卖出,11822普通股, $11.16
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 425 - Prospectuses and communications, business combinations Filed: 2017-04-18 AccNo: 0001104659-17-024184 Size: 40 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-04-18 AccNo: 0001104659-17-024183 Size: 40 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 425 - Prospectuses and communications, business combinations Filed: 2017-04-18 AccNo: 0001104659-17-024182 Size: 19 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-13,10% Owner,HBM Healthcare Investments (Ca ,卖出,10984普通股, $11.13
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-12,10% Owner,HBM Healthcare Investments (Ca ,卖出,13250普通股, $11.22